Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma
To investigate the association of discordance in patient- and physician-reported symptoms on health-related quality of life (HRQoL) in hepatocellular carcinoma (HCC). Data were drawn from a point-in-time survey of physicians and patients conducted in Germany, Italy and Spain (October 2018 – January...
Gespeichert in:
Veröffentlicht in: | Future oncology (London, England) England), 2022-10, Vol.18 (33), p.3727-3740 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3740 |
---|---|
container_issue | 33 |
container_start_page | 3727 |
container_title | Future oncology (London, England) |
container_volume | 18 |
creator | Leith, Andrea Kiiskinen, Urpo Girvan, Allicia C Jen, Min-Hua Khela, Keerun Rider, Alex Massey, Lucy Piercy, James |
description | To investigate the association of discordance in patient- and physician-reported symptoms on health-related quality of life (HRQoL) in hepatocellular carcinoma (HCC).
Data were drawn from a point-in-time survey of physicians and patients conducted in Germany, Italy and Spain (October 2018 – January 2019). Physicians and their consulting patients independently reported baseline characteristics, symptoms, treatment history and satisfaction, and HRQoL derived using the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) questionnaire.
Of 486 patients analysed, tiredness (73.3%, 73.7%), pain/aches (67.7%, 66.9%) and weight/appetite loss (54.3%, 53.7%) were the most common and concordant patient and physician-reported symptom domains, respectively. The symptom domains showing the largest discordance were reflux/indigestion (14.6%, 5.1%), neurological (11.9%, 5.6%), dermatological (9.3%, 6.2%) symptoms and jaundice (4.7%, 10.3%). Reduced HRQoL was observed with increasing symptom-reporting discordance.
Further studies should investigate how symptom-reporting discordance influences patient satisfaction and HRQoL. |
doi_str_mv | 10.2217/fon-2022-0202 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2736663189</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2736663189</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-24bb8ac9740e83a1ddb60fd872d9f4c0dda61de94265b1bb384038fcf7a861323</originalsourceid><addsrcrecordid>eNp1kLuPFSEUh4nRuA8tbQ2lDSuvBaY0G1dNNtFCa8LAIRczA7PAxNz_Xq53tbM5j-Q7v5x8CL1h9IZzpt_HkgmnnBM66jN0ybSUxAjKno9Z6okoNckLdNXaT0qlFrf0JboQSmhtmLlE_dvh2JJPLhPscsCb6wlyJxW2UjsE3I7r1suKfcm-1OCyhz-ga62Ms55Kxr9SP-DH3S2pH3GJeEkRcMr4ACOueFiWfXEVe1d9ymV1r9CL6JYGr5_6Nfpx__H73Wfy8PXTl7sPD8QLYTrhcp6N85OWFIxwLIRZ0RiM5mGK0tMQnGIBJsnV7czmWRhJhYk-amcUE1xco3fn3K2Wxx1at2tqp3dchrI3y7VQSglmpoGSM-praa1CtFtNq6tHy6g9ibZDtD2JtifRg3_7FL3PK4R_9F-zA5jOQNz7XqH5odWDPW_jYjjP8J_w38vTj4k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2736663189</pqid></control><display><type>article</type><title>Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma</title><source>MEDLINE</source><source>PubMed Central</source><creator>Leith, Andrea ; Kiiskinen, Urpo ; Girvan, Allicia C ; Jen, Min-Hua ; Khela, Keerun ; Rider, Alex ; Massey, Lucy ; Piercy, James</creator><creatorcontrib>Leith, Andrea ; Kiiskinen, Urpo ; Girvan, Allicia C ; Jen, Min-Hua ; Khela, Keerun ; Rider, Alex ; Massey, Lucy ; Piercy, James</creatorcontrib><description>To investigate the association of discordance in patient- and physician-reported symptoms on health-related quality of life (HRQoL) in hepatocellular carcinoma (HCC).
Data were drawn from a point-in-time survey of physicians and patients conducted in Germany, Italy and Spain (October 2018 – January 2019). Physicians and their consulting patients independently reported baseline characteristics, symptoms, treatment history and satisfaction, and HRQoL derived using the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) questionnaire.
Of 486 patients analysed, tiredness (73.3%, 73.7%), pain/aches (67.7%, 66.9%) and weight/appetite loss (54.3%, 53.7%) were the most common and concordant patient and physician-reported symptom domains, respectively. The symptom domains showing the largest discordance were reflux/indigestion (14.6%, 5.1%), neurological (11.9%, 5.6%), dermatological (9.3%, 6.2%) symptoms and jaundice (4.7%, 10.3%). Reduced HRQoL was observed with increasing symptom-reporting discordance.
Further studies should investigate how symptom-reporting discordance influences patient satisfaction and HRQoL.</description><identifier>ISSN: 1479-6694</identifier><identifier>EISSN: 1744-8301</identifier><identifier>DOI: 10.2217/fon-2022-0202</identifier><identifier>PMID: 36377818</identifier><language>eng</language><publisher>England: Future Medicine Ltd</publisher><subject>Carcinoma, Hepatocellular - diagnosis ; Carcinoma, Hepatocellular - epidemiology ; Carcinoma, Hepatocellular - therapy ; concordance ; health-related quality of life ; hepatocellular carcinoma ; Humans ; Liver Neoplasms - complications ; Liver Neoplasms - diagnosis ; Liver Neoplasms - therapy ; Pain ; Patient Reported Outcome Measures ; Physicians ; Quality of Life ; real-world survey ; Surveys and Questionnaires ; symptoms</subject><ispartof>Future oncology (London, England), 2022-10, Vol.18 (33), p.3727-3740</ispartof><rights>2022 Adelphi Real World</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c338t-24bb8ac9740e83a1ddb60fd872d9f4c0dda61de94265b1bb384038fcf7a861323</cites><orcidid>0000-0002-4916-0107 ; 0000-0002-8656-002X ; 0000-0003-0394-2303 ; 0000-0002-7869-3543 ; 0000-0003-3487-5609 ; 0000-0002-1147-5306 ; 0000-0003-0791-940X ; 0000-0001-7015-1021</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36377818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leith, Andrea</creatorcontrib><creatorcontrib>Kiiskinen, Urpo</creatorcontrib><creatorcontrib>Girvan, Allicia C</creatorcontrib><creatorcontrib>Jen, Min-Hua</creatorcontrib><creatorcontrib>Khela, Keerun</creatorcontrib><creatorcontrib>Rider, Alex</creatorcontrib><creatorcontrib>Massey, Lucy</creatorcontrib><creatorcontrib>Piercy, James</creatorcontrib><title>Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma</title><title>Future oncology (London, England)</title><addtitle>Future Oncol</addtitle><description>To investigate the association of discordance in patient- and physician-reported symptoms on health-related quality of life (HRQoL) in hepatocellular carcinoma (HCC).
Data were drawn from a point-in-time survey of physicians and patients conducted in Germany, Italy and Spain (October 2018 – January 2019). Physicians and their consulting patients independently reported baseline characteristics, symptoms, treatment history and satisfaction, and HRQoL derived using the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) questionnaire.
Of 486 patients analysed, tiredness (73.3%, 73.7%), pain/aches (67.7%, 66.9%) and weight/appetite loss (54.3%, 53.7%) were the most common and concordant patient and physician-reported symptom domains, respectively. The symptom domains showing the largest discordance were reflux/indigestion (14.6%, 5.1%), neurological (11.9%, 5.6%), dermatological (9.3%, 6.2%) symptoms and jaundice (4.7%, 10.3%). Reduced HRQoL was observed with increasing symptom-reporting discordance.
Further studies should investigate how symptom-reporting discordance influences patient satisfaction and HRQoL.</description><subject>Carcinoma, Hepatocellular - diagnosis</subject><subject>Carcinoma, Hepatocellular - epidemiology</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>concordance</subject><subject>health-related quality of life</subject><subject>hepatocellular carcinoma</subject><subject>Humans</subject><subject>Liver Neoplasms - complications</subject><subject>Liver Neoplasms - diagnosis</subject><subject>Liver Neoplasms - therapy</subject><subject>Pain</subject><subject>Patient Reported Outcome Measures</subject><subject>Physicians</subject><subject>Quality of Life</subject><subject>real-world survey</subject><subject>Surveys and Questionnaires</subject><subject>symptoms</subject><issn>1479-6694</issn><issn>1744-8301</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLuPFSEUh4nRuA8tbQ2lDSuvBaY0G1dNNtFCa8LAIRczA7PAxNz_Xq53tbM5j-Q7v5x8CL1h9IZzpt_HkgmnnBM66jN0ybSUxAjKno9Z6okoNckLdNXaT0qlFrf0JboQSmhtmLlE_dvh2JJPLhPscsCb6wlyJxW2UjsE3I7r1suKfcm-1OCyhz-ga62Ms55Kxr9SP-DH3S2pH3GJeEkRcMr4ACOueFiWfXEVe1d9ymV1r9CL6JYGr5_6Nfpx__H73Wfy8PXTl7sPD8QLYTrhcp6N85OWFIxwLIRZ0RiM5mGK0tMQnGIBJsnV7czmWRhJhYk-amcUE1xco3fn3K2Wxx1at2tqp3dchrI3y7VQSglmpoGSM-praa1CtFtNq6tHy6g9ibZDtD2JtifRg3_7FL3PK4R_9F-zA5jOQNz7XqH5odWDPW_jYjjP8J_w38vTj4k</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Leith, Andrea</creator><creator>Kiiskinen, Urpo</creator><creator>Girvan, Allicia C</creator><creator>Jen, Min-Hua</creator><creator>Khela, Keerun</creator><creator>Rider, Alex</creator><creator>Massey, Lucy</creator><creator>Piercy, James</creator><general>Future Medicine Ltd</general><scope>FUMOA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4916-0107</orcidid><orcidid>https://orcid.org/0000-0002-8656-002X</orcidid><orcidid>https://orcid.org/0000-0003-0394-2303</orcidid><orcidid>https://orcid.org/0000-0002-7869-3543</orcidid><orcidid>https://orcid.org/0000-0003-3487-5609</orcidid><orcidid>https://orcid.org/0000-0002-1147-5306</orcidid><orcidid>https://orcid.org/0000-0003-0791-940X</orcidid><orcidid>https://orcid.org/0000-0001-7015-1021</orcidid></search><sort><creationdate>20221001</creationdate><title>Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma</title><author>Leith, Andrea ; Kiiskinen, Urpo ; Girvan, Allicia C ; Jen, Min-Hua ; Khela, Keerun ; Rider, Alex ; Massey, Lucy ; Piercy, James</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-24bb8ac9740e83a1ddb60fd872d9f4c0dda61de94265b1bb384038fcf7a861323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Carcinoma, Hepatocellular - diagnosis</topic><topic>Carcinoma, Hepatocellular - epidemiology</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>concordance</topic><topic>health-related quality of life</topic><topic>hepatocellular carcinoma</topic><topic>Humans</topic><topic>Liver Neoplasms - complications</topic><topic>Liver Neoplasms - diagnosis</topic><topic>Liver Neoplasms - therapy</topic><topic>Pain</topic><topic>Patient Reported Outcome Measures</topic><topic>Physicians</topic><topic>Quality of Life</topic><topic>real-world survey</topic><topic>Surveys and Questionnaires</topic><topic>symptoms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leith, Andrea</creatorcontrib><creatorcontrib>Kiiskinen, Urpo</creatorcontrib><creatorcontrib>Girvan, Allicia C</creatorcontrib><creatorcontrib>Jen, Min-Hua</creatorcontrib><creatorcontrib>Khela, Keerun</creatorcontrib><creatorcontrib>Rider, Alex</creatorcontrib><creatorcontrib>Massey, Lucy</creatorcontrib><creatorcontrib>Piercy, James</creatorcontrib><collection>Future Medicine (Open Access)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Future oncology (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leith, Andrea</au><au>Kiiskinen, Urpo</au><au>Girvan, Allicia C</au><au>Jen, Min-Hua</au><au>Khela, Keerun</au><au>Rider, Alex</au><au>Massey, Lucy</au><au>Piercy, James</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma</atitle><jtitle>Future oncology (London, England)</jtitle><addtitle>Future Oncol</addtitle><date>2022-10-01</date><risdate>2022</risdate><volume>18</volume><issue>33</issue><spage>3727</spage><epage>3740</epage><pages>3727-3740</pages><issn>1479-6694</issn><eissn>1744-8301</eissn><abstract>To investigate the association of discordance in patient- and physician-reported symptoms on health-related quality of life (HRQoL) in hepatocellular carcinoma (HCC).
Data were drawn from a point-in-time survey of physicians and patients conducted in Germany, Italy and Spain (October 2018 – January 2019). Physicians and their consulting patients independently reported baseline characteristics, symptoms, treatment history and satisfaction, and HRQoL derived using the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) questionnaire.
Of 486 patients analysed, tiredness (73.3%, 73.7%), pain/aches (67.7%, 66.9%) and weight/appetite loss (54.3%, 53.7%) were the most common and concordant patient and physician-reported symptom domains, respectively. The symptom domains showing the largest discordance were reflux/indigestion (14.6%, 5.1%), neurological (11.9%, 5.6%), dermatological (9.3%, 6.2%) symptoms and jaundice (4.7%, 10.3%). Reduced HRQoL was observed with increasing symptom-reporting discordance.
Further studies should investigate how symptom-reporting discordance influences patient satisfaction and HRQoL.</abstract><cop>England</cop><pub>Future Medicine Ltd</pub><pmid>36377818</pmid><doi>10.2217/fon-2022-0202</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-4916-0107</orcidid><orcidid>https://orcid.org/0000-0002-8656-002X</orcidid><orcidid>https://orcid.org/0000-0003-0394-2303</orcidid><orcidid>https://orcid.org/0000-0002-7869-3543</orcidid><orcidid>https://orcid.org/0000-0003-3487-5609</orcidid><orcidid>https://orcid.org/0000-0002-1147-5306</orcidid><orcidid>https://orcid.org/0000-0003-0791-940X</orcidid><orcidid>https://orcid.org/0000-0001-7015-1021</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1479-6694 |
ispartof | Future oncology (London, England), 2022-10, Vol.18 (33), p.3727-3740 |
issn | 1479-6694 1744-8301 |
language | eng |
recordid | cdi_proquest_miscellaneous_2736663189 |
source | MEDLINE; PubMed Central |
subjects | Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - therapy concordance health-related quality of life hepatocellular carcinoma Humans Liver Neoplasms - complications Liver Neoplasms - diagnosis Liver Neoplasms - therapy Pain Patient Reported Outcome Measures Physicians Quality of Life real-world survey Surveys and Questionnaires symptoms |
title | Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T06%3A24%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physician-%20and%20patient-reported%20symptom%20concordance%20and%20association%20with%20quality%20of%20life%20in%20hepatocellular%20carcinoma&rft.jtitle=Future%20oncology%20(London,%20England)&rft.au=Leith,%20Andrea&rft.date=2022-10-01&rft.volume=18&rft.issue=33&rft.spage=3727&rft.epage=3740&rft.pages=3727-3740&rft.issn=1479-6694&rft.eissn=1744-8301&rft_id=info:doi/10.2217/fon-2022-0202&rft_dat=%3Cproquest_cross%3E2736663189%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2736663189&rft_id=info:pmid/36377818&rfr_iscdi=true |